Desheng Weng Selected Research

TES

7/2010

Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Desheng Weng Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 01/2009
4	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 01/2010
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 11/2019
3	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2012
3	Carcinogenesis 01/2022 - 07/2010
3	Carcinoma (Carcinomatosis) 10/2011 - 01/2009
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2010
1	Neuroendocrine Carcinoma 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Triple Negative Breast Neoplasms 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Dermatofibrosarcoma 01/2018
1	Neck Pain (Cervicalgia) 07/2015
1	Chest Pain (Chest Pains) 07/2015
1	Nasopharyngeal Carcinoma 05/2013
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2012
1	Animal Mammary Neoplasms 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 10/2009
1	Necrosis 07/2003
1	Bronchitis 07/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2003
5	VaccinesIBA 01/2023 - 01/2010
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023 - 01/2010
4	Cancer VaccinesIBA 01/2023 - 01/2010
4	Molecular Chaperones (Chaperone, Molecular)IBA 01/2023 - 01/2011
4	Peptides (Polypeptides)IBA 01/2023 - 01/2010
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2013
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 01/2011
2	Messenger RNA (mRNA)IBA 01/2018 - 07/2010
2	Complement System Proteins (Complement)IBA 07/2013 - 01/2010
1	CateninsIBA 03/2024
1	toripalimabIBA 01/2024
1	surufatinibIBA 01/2024
1	InterleukinsIBA 01/2023
1	AlarminsIBA 01/2023
1	Fluorouracil (Carac)FDA LinkGeneric 01/2023
1	Interleukin-33IBA 01/2023
1	lenvatinibIBA 01/2023
1	Deubiquitinating EnzymesIBA 11/2022
1	Annexin A5IBA 01/2022
1	serum P-component (CIt)IBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	Circular RNAIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	PlatinumIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 11/2021
1	MAP-kinase-activated kinase 2IBA 11/2021
1	Protein Kinases (Protein Kinase)IBA 11/2021
1	ChemokinesIBA 11/2021
1	Therapeutic UsesIBA 11/2021
1	HSP27 Heat-Shock ProteinsIBA 11/2021
1	LigandsIBA 11/2021
1	Axitinib (AG 013736)IBA 05/2021
1	pazopanib FDA Link 05/2021
1	Chimeric Antigen ReceptorsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Competitive Endogenous RNAIBA 11/2019
1	Sunitinib (Sutent)FDA Link 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	VimentinIBA 07/2015
1	CollagenIBA 07/2015
1	Combined VaccinesIBA 07/2013
1	ProteomeIBA 05/2013
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2012
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2011
1	TESIBA 07/2010
1	OligonucleotidesIBA 01/2010
1	AntigensIBA 10/2009
1	Lamin Type A (Lamin A)IBA 01/2009

Therapy/Procedure

7	Therapeutics 01/2023 - 10/2009
5	Drug Therapy (Chemotherapy) 10/2023 - 10/2011
4	Immunotherapy 01/2023 - 07/2013
3	Radiotherapy 01/2022 - 01/2010
1	Mastectomy (Mammectomy) 01/2022
1	Nephrectomy 05/2021
1	Neoadjuvant Therapy 05/2021
1	Craniotomy 07/2015